Why Clover Health Might Not Bring You Good Luck
The innovative health insurer presents an intriguing — but flawed — risk-to-reward profile.
The innovative health insurer presents an intriguing — but flawed — risk-to-reward profile.
Not every name Berkshire Hathaway holds is right for all investors, but any of these three picks would be…
If a market downturn is looming, you need to be prepared.
Big-time bargains can still be found in this high-growth index.
The latest Marvel movie kept big-screen showings packed, which bodes well for this company’s upcoming quarterly reports.
It’s been a great year for leading cryptocurrencies, but new regulatory concerns may be on the horizon.
CrowdStrike continues to grow its business at a rapid pace.
It’s time to take a second look at this tech stock.